Hemab Therapeutics Holdings (COAG) Price to Book Value: 4.262

Hemab Therapeutics Holdings, Inc. (COAG)

41.45 +1.03 (+2.55%) USD | NASDAQ | Oct 30, 16:00

41.45 0.00 (0.00%) After-Hours: 20:00

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2026. Start Trial.

Date	Value
October 30, 2026	4.262
October 29, 2026	4.156
October 28, 2026	3.958
October 27, 2026	3.948
October 26, 2026	3.703
October 23, 2026	3.537
October 22, 2026	3.580
October 21, 2026	3.633
October 20, 2026	3.513
October 19, 2026	3.299
October 16, 2026	3.092
October 15, 2026	3.344
October 14, 2026	3.078
October 13, 2026	3.064
October 12, 2026	3.124
October 09, 2026	3.251
October 08, 2026	3.176
October 07, 2026	2.951
October 06, 2026	2.917
October 05, 2026	3.145
October 02, 2026	3.198
October 01, 2026	3.193
September 30, 2026	3.171
September 29, 2026	3.352
September 28, 2026	3.405

Date	Value
September 25, 2026	3.572
September 24, 2026	3.672
September 23, 2026	3.776
September 22, 2026	3.933
September 21, 2026	3.904
September 18, 2026	4.235
September 17, 2026	4.238
September 16, 2026	4.212
September 15, 2026	4.124
September 14, 2026	4.161
September 11, 2026	4.051
September 10, 2026	4.100
September 09, 2026	4.575
September 08, 2026	4.582
September 04, 2026	4.566
September 03, 2026	4.562
September 02, 2026	4.596
September 01, 2026	4.526
August 31, 2026	4.702
August 28, 2026	4.610
August 27, 2026	5.088
August 26, 2026	5.057
August 25, 2026	5.105
August 24, 2026	4.798
August 21, 2026	5.054

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks